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Background: Amid continuing social unrest from the Great East Japan Earthquake and subsequent Fukushima
nuclear accident of 2011, the Japanese government announced plans for a major biobanking project in the
disaster-stricken areas, to be administered by the ‘Tohoku Medical Megabank Organization’ (ToMMo). This project
differs from previous biobanking projects in that it 1) was initiated mainly to boost post-disaster recovery and
reconstruction; and 2) targets the area’s survivors as its primary subjects. Here, we review the ethics of the ToMMo
biobanking project within the wider context of disaster remediation.
Discussion: Private citizens in the Tohoku region have criticized the project proposal, asking for further review of
the ethics of targeting disaster survivors for this study. They claim the project violates the Declaration of Helsinki’s
ethical provisions in that (1) government and university researchers initiated it without consulting any Tohoku survivors;
(2) survivors already suffering extreme losses may view study involvement as meaningless or even undesirable, yet feel
forced to participate in exchange for tenuous promises of future assistance, thus exploiting those most in need.
Although the ToMMo has promised certain future social benefits for the target population in exchange for participating
in its biobanking research, it is questionable whether such research can address the immediate health needs of the
Tohoku disaster survivors in any significant fashion. The ethics of recruiting still-struggling survivors is also questionable.
Summary: This case analysis demonstrates that conducting a post-disaster biobanking project on survivors poses issues
concerning potential exploitation and the just distribution of benefits and burdens. Though the ToMMo emphasizes
the project’s importance for individual survivors and regional recovery, it is questionable whether such research can
justly respond to the survivors’ immediate health needs and whether truly voluntary participation can be ensured
in such a crisis. Our society must enhance this nationwide debate and reexamine our priorities for recovery in the
disaster-stricken regions. We should evaluate both whether and how this project can truly contribute to the survivors’
quality of life.
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On May 16, 2011 the Ministry of Education, Culture,
Sports, Science and Technology (MEXT) and the Ministry
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The notice requested that all surveys and other research
conducted in the Great East Japan Earthquake-stricken
areas:
1. Undergo advance review with a research ethics
review committee, based on relevant governmental
ethics guidelines;
2. Undergo advance consultation by relevant local
governments within and surrounding disaster-stricken
areas, with due regard for the needs of disasterentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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healthcare and other services as needed; and
3. Avoid any overlap with similar existing surveys or
research, so as to minimize their number.
This notice was prompted by issues raised by various
academic associations, including the Japanese Society of
Psychiatry and Neurology (JSPN). In an urgent official
statement issued April 28, 2011, the JSPN claimed that
many unnecessary, overly burdensome, ethically question-
able, and/or exploitative research projects – not only med-
ical but also social and behavioral – had been conducted
in the stricken areas immediately after the disaster [2].
Among them, the largest and most controversial was
the biobanking project, involving a genetic epidemiological
study implemented by the Tohoku Medical Megabank
Organization (ToMMo) at Tohoku University, one of
Japan’s elite universities [3].
The most critical opposition to the ToMMo’s biobank
project (ToMMo-BbP) came from a citizens’ group called
the Miyagi Residents Center of the Post-Great East Japan
Earthquake Recovery and Reconstruction Supports (MRC).
On February 16, 2012, the MRC sent a letter of concern
to all medical and healthcare institutions, political parties,
and local governments in the Miyagi Prefecture entitled,
“We require thoughtful re-consideration among concerned
parties regarding the grand design of the ToMMo-BbP
[4].” Their opposition stemmed mainly from what they
perceived as significant conflicts between governmental
aims, the ToMMo-BbP’s research goals, and the survivors’
immediate and long-term needs. That is, the government’s
primary aim is reconstruction of quake-hit areas and eco-
nomic recovery; ToMMo-BbP goals are to collect genetic
samples and health data on survivors for a large-scale,
decades-long, population-based genetic cohort study,
including pediatric sub-cohorts, while the survivors’ prior-
ities are to re-establish livelihoods and quality of life.
As background, population-based cohort studies usually
target generally healthy communities and are conducted
in areas where population flux is low. For instance, Iwate
Prefecture (a disaster-stricken area) has a well-known,
on-going cardiovascular cohort study, the Ohasama Study,
which has monitored at-home blood pressures for about
30 years [5]. Among such cohort studies, those that
include genetic data as potentially explanatory variables
are called “genetic cohort studies.” There are at least
30 such genetic cohort studies in Japan, ranging from
thousands to tens of thousands of cohorts [6]. Yet, quite
atypically, the ToMMo-BbP was initiated by the Japanese
government in order to boost post-disaster recovery and
reconstruction, while targeting disaster survivors as its
primary participants.
What are the consequences of targeting survivors rather
than a healthy, unaffected population? In this paper, weexamine this issue by reviewing the disaster’s aftermath
with particular focus on the disaster regions’ in situ
healthcare system and the details of the ToMMo-BbP
study. We then discuss ethical issues with respect to the
ToMMo-BbP, and conclude that the project’s design and
implementation remain ethically problematic.
Note that this study refers only to the 2008 version of
the Declaration of Helsinki (DoH), which was current
when the ToMMo-BbP was initiated [7]. However, though
the relevant sections (Provisions 17 and 26) of the DoH
were indeed revised in 2013, the revisions remain altogether
in accord with our present discussion. Also note that the
forgoing analysis is based solely on documents and data
sources currently published and publicly available. Thus,
any aspects and/or changes to the ToMMo-BbP design, not
available at the time of writing, are not reflected in the
present manuscript.
Discussion
Case presentation: Great East Japan Earthquake and the
ToMMo biobank project
More than 15,800 people died due to the earthquake on
March 11, 2011. Over 2,600 people remain missing [8], and
as of July 30, 2013 more than 290,000 remain displaced [9].
According to the MHLW’s report of July 11, 2011
[10,11], of the 380 hospitals in Tohoku’s three most-
damaged prefectures – Iwate, Miyagi, and Fukushima – 10
(2.6%) were completely destroyed and 290 (76.3%) were
severely damaged. Moreover, 83 (2.1%) of the 4,036 medical
clinics and 83 (3.2%) of 2,597 dental clinics suffered
complete collapse; 1,173 (29.1%) and 820 (31.6%) were
partly destroyed; and 875 (12.1%) of the 7,206 social
welfare facilities for children, elderly, and disabled persons
were damaged or destroyed. About 30–40% of the dam-
aged or destroyed facilities were, and many still are, closed
or unable to receive patients. Furthermore, about 40%
of the survivors, as well as 10% to 20% of local physi-
cians report on-going health issues stemming from the
disaster [12-14].
Long before the 2011 quake, along with rapid aging and
depopulation Tohoku was already suffering from serious
shortages in medical resources and personnel. Among
Japan’s 47 prefectures, the number of physicians per
100,000 population, Iwate, Miyagi, and Fukushima ranked
37th, 27th, and 39th, respectively. Similarly, by nurses per
100,000, they ranked 14th, 33rd, and 38th, respectively [15].
Immediately after the disaster, the number of medical
professionals dispatched as acute aid from intact medical
institutions from all over Japan totaled about 10,000.
However, the average daily number of active personnel
was 500. And this number decreased significantly within
two months of the disaster [11]. On the other hand, more
than 1,200 local medical professionals in the stricken areas
left their jobs [16]. Consequently, healthcare in already
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especially in tsunami-ravaged coastal, rural regions remote
from Tohoku’s central urban areas, such as Sendai City
where Tohoku University is located.
In June 2011, during continuing social ferment stem-
ming from the tsunami and ensuing Fukushima nuclear
melt-down, the biobanking project was initially proposed
and discussed by the Reconstruction Design Council and
the Cabinet level Conference on Medical Innovation.
The ToMMo was then established in February 2012 at
Tohoku University and funded by the MEXT with 15.8
billion Yen (US$ 207 million) (which is 5.78% of the
MEXT’s Science and Technology Budget in FY2011).
Major funding was allocated through the government’s
Special Reconstruction Budget, intended primarily to
boost the economy and replace destroyed or damaged
infrastructure.
The MEXT has stated that the primary goal of the
ToMMo-BbP is to aid Tohoku’s economic recovery by
establishing a center for a new healthcare industry, and
promote nation-wide medical innovations, while creating
a new, model healthcare system [17]. To achieve these
goals, the ToMMo-BbP includes three major projects
[18]: (i) creation of a massive genetic biobank with sam-
ples from 150,000 people, including disaster sufferers,
healthy people, and children, with the aim of propelling
nation-wide medical innovation, as well as establishing
individualized medicine and preventive care through
combined analyses of genetic and healthcare informa-
tion; (ii) establishment of a model, regional healthcare
IT network that shares patient healthcare records among
medical institutions electronically; and (iii) the develop-
ment of a pool of biomedical science professionals, such
as clinical research coordinators, data managers, genetic
counselors, bioinformation specialists, science communi-
cators, and medical system engineers, needed to mount a
nation-wide program of medical innovation.
To support the above projects, the ToMMo-BbP will
collect biomaterials, including genetic samples and clinical
information through an IT-networked, electronic patient
healthcare records system in the damaged regions, from
80,000 disaster victims and 70,000 healthy individuals,
derived from about 10,000 three-generation families (i.e.
grandparents, parents, and grand-children, including
expected newborns).
Prior to the 2011 earthquake, Tohoku was a region with
low migration rates. There were many three-generation
families in the same household or within close proximity.
Therefore, establishing a large, multi-generational biobank
and tracking its participants is easier in Tohoku than
other areas of Japan. As incentives in exchange for bio-
bank data, personal health data will be archived and free
health-checkups will be offered. Also, young physician-
researchers will be dispatched on one-year clinicalfellowships to medical facilities in the disaster-stricken
areas. Such fellowships will provide clinical services in
three shifts of four months each in the stricken areas,
help recruit biobank participants, then return to the
University for 8 months to perform lab analyses and
undergo further training in innovative clinical practice
and skills. The first team of four physician-researchers
was dispatched on October 2012 [19].
Moreover, new training courses will start at the
Tohoku University Graduate School of Medicine and
the newly-planned Graduate School of Public Health, to
develop medical science professionals who are expected
to embark on careers in medical research [18].
The ToMMo states that all of these biobank-mediated
reconstruction programs will help restore the regional
healthcare system, as well as boost Tohoku’s general
economy.
Grass-roots criticism and the Declaration of Helsinki
However, some argue that the project is fishing unethic-
ally in troubled waters – conducting a major biobanking
study on survivors already laboring under the dual load of
earthquake recovery and Tohoku’s pre-existing, substand-
ard healthcare system. Taken together, this suggests that
such cohorts are at greater risk of exploitation via such
research. Dr. Hideki Komatsu, the Hospital Vice President
of Kameda Medical Center in Chiba, which has provided
substantial medical support to the disaster-stricken areas,
has criticized the ToMMo-BbP and its priorities bitterly
[20]. He views as inappropriate the use of funds from the
Special Reconstruction Budget for this project because
it will mainly benefit researchers and large businesses
rather than its designated target population, the disaster
survivors themselves. Such survivors, in real need of liveli-
hood resuscitation, may never benefit in any significant
fashion. Komatsu says, “Some may argue that survivors will
also prosper if the wind blows. However, once we accept
such logic, then any unrelated plan can be linked in turn to
the Reconstruction projects.” Dr. Hidetoshi Mitobe, himself
a disaster survivor and MRC organizer, also levied similar
criticism. Mitobe claimed that [4,21]: (1) though the current
focus should be on disaster recovery, the ToMMo-BbP
was initiated by the national government and university
researchers without consultation or dialog with either
local governments around the disaster-stricken areas or
the disaster survivors themselves; (2) whether the project
is really desirable for survivors suffering great stress due
to loss of homes, families, communities, and even hopes
is quite dubious; (3) a project harboring such critical
doubts regarding benefit to the target research population
infringes on Provisions 17 and 26 of the Declaration of
Helsinki (2008).
Provision 17 of the DoH (in the 2008 text) states that
“Medical research involving a disadvantaged or vulnerable
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is responsive to the health needs and priorities of this
population or community and if there is a reasonable
likelihood that this population or community stands to
benefit from the results of the research [7].” Indeed,
Provision 17 strengthens Provisions 19 and 30 of the old
DoH of 2000, and was developed in response to the 1990s
controversy regarding randomized trials of a shorter-course
regimen of zidovudine to prevent maternal-fetal Human
Immunodeficiency Virus transmission in developing coun-
tries [22]. Two additional criteria: responsiveness and
reasonable availability, were introduced to justify research
on impoverished populations in developing countries.
However, such criteria are not limited to developing
nations. Although debate is on-going as to the inter-
pretation and implications of these provisions [23-25],
Mitobe claimed that Provision 17 renders the project in
violation of the DoH and thus “unethical” [21].
Moreover, Mitobe claims that the project violates the
Helsinki declaration because Provision 26 clearly states
that, “When seeking informed consent for participation
in a research study the physician should be particularly
cautious if the potential subject is in a dependent relation-
ship with the physician or may consent under duress. In
such situations the informed consent should be sought by
an appropriately qualified individual who is completely
independent of this relationship.” Yet, the ToMMo-BbP
plans to obtain consent in exchange for supplying the
disaster-stricken regions with researcher-physicians whose
primary aim is to conduct genetic research [21].
Meanwhile, prior to implementation, the MEXT formed
an internal advisory committee to study the overall design
of the ToMMo-BbP, including any ethical issues. The
committee met five times between April and May 2012
and submitted final recommendations to the MEXT on
June 7, 2012 [26]. Concerning ethical issues, they set forth
four priorities: 1) assessing the project’s compliance with
relevant ethics guidelines for research; 2) setting up an
expert task force to formulate ethical policies for those
involved in the project; 3) preparing a model for informed
‘broad consent’ for biobanking; and 4) ensuring that such
informed consent is truly voluntary [26-30].
Their final recommendations emphasized the project’s
need to consult with local communities and contribute
to recovery in the quake-stricken areas. However, the
main concern of Komatsu and Mitobe, potential violation
of DoH provisions regarding exploitation of survivor
subjects, was never discussed. In fact, none of the
committee members referred to any of the relevant
provisions of the DoH nor ethical issues concerning
research on vulnerable populations. The committee
simply emphasized a broad expectation that the pro-
ject be a driving force for health care innovation and
post-disaster recovery [26].The ToMMo-BbP protocol was also reviewed and
approved by an institutional ethics review committee at
Tohoku University. Additionally the ToMMo itself set
up a task force to exam ethical, legal, and social issues
(ELSI) concerning their biobanking project. However,
as of April 2014, the committee’s minutes, the ToMMo
selection process, list of task force members, and task
force discussions regarding the ELSI remain unavailable
for public review [31].
Ethical analysis I: validity of biobanking with disaster
survivors – responsiveness and reasonable availability
concerns
As stated in the 2008 DoH, provision 17, the responsive-
ness and reasonable availability require that research on
disadvantaged populations prioritizes the subjects’ health
needs and ensures that individual subjects retain reason-
able access to research findings involving themselves
[32-34]. Accordingly, some claim that the ToMMo-BbP will
lessen the current inequities in Tohoku’s long-standing,
substandard healthcare infrastructure, thereby achieving
multiple local and national goals [17,35-40]. Supplemental
to regular health checkups for disaster survivors, the
project, while establishing a massive biobank for a genetic
cohort study, will also prompt earlier detection and thus
treatment of cancers, cerebro-cardiovascular diseases,
diabetes, mental disorders and other common afflictions
[41]. While monitoring each individual for decades, it will
also collect and store biological materials and individual
healthcare and lifestyle-related information, study cor-
relations, and disseminate bulk research materials and
information to various third parties. Through these
activities the ToMMo-BbP project expects to establish a
national foundation for future personalized and preventive
health care.
With the reconstruction and creation of industrialized
healthcare in Kobe after the Great Hanshin-Awaji Earth-
quake of 1995 as its model [42,43], the ToMMo-BbP
also proposes to catalyze to be clustering of healthcare
industries in Tohoku, as it gathers people, medical
professionals, and capital investment, promotes local
employment, and restores and improves health care in
the disaster regions. Thus, the project may boost health
care innovation and economic growth, not only in Tohoku
but also nation-wide, as well as mitigate “brain drain” from
the region by encouraging medical professionals and new
graduates to remain in or relocate to Tohoku (Table 1).
Accordingly, as Emanuel et al. suggests, in the broadest
view, the ToMMo-BbP may justify itself by providing a
“fair benefit” [23-25].
However this can be expected, provided such added
benefits are reasonably foreseeable, and agreement on
the amount and distribution of such benefits is achieved
among all parties concerned. Certainly, the estimated
Table 1 Argued potential benefits from the Tohoku Medical Megabank Organization’s biobank project
Beneficiary Short-term benefits Long-term benefits
Individual research subjects Free additional health examinations in addition to
those given by the national health-checkup program
Individual health will be years-long watched over with
loving eyes by the researchers
Receiving individual results of the proven baseline
health examinations
Discovered clinically-assessed individual genetic risk
information as well as incidental findings will be returned
Specialist referral services
Local communities in the
quake-hit regions
Deployment of young researcher-physicians for
clinical services in three shifts of four months each
in quake-hit areas
Repairment of the damaged local healthcare system
Mitigation of brain drain Solving a shortage of medical resources
Promotion of local investment and employment Improvement of the Tohoku’s long-standing substandard
healthcare infrastructure
Clustering healthcare industries
Boosting the general local economy
Attracting young people and medical professionals to
move into the region
Access to epidemiological findings on quake-/stress-
induced diseases
National population None Economic recovery
Promotion of medical innovations
Creation of a model of a new healthcare system combined
with the healthcare IT network
Materialization of personalized medicine and prevention
through a huge human genetic database and results of
the cohort study
Table 2 Immediate health-related needs of the
quake-survivors at the initial proposal of the ToMMo-BbP
(June 2011)
Individual needs Secured access to medical resources and
healthcare services
Specific treatments and care
Real measures for individual livelihood
rehabilitation
Communities’ needs Rapid recovery of the collapsed local
healthcare system
Additional hundreds of battle-ready medical
and healthcare staff
More access to medical facilities and resources
Recovery of livelihood including returning
original homes/communities
Abbreviation: ToMMo-BbP the Tohoku Medical Megabank Organization’s
biobank project.
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resources remains speculative. Indeed, 18 years after the
disaster, the reality for Kobe is only partial success, with
full recovery of the local economy and healthcare system
still to be achieved [44].
Yet, uncertain execution and impacts cannot serve as
an ethical hurdle to impede research. Rather, if there is
good reason to believe that the balance between burdens
and potential benefits seems sufficient, it may be considered
as fair research [45]. In fact, the ToMMo-BbP’s anticipated
benefit to Tohoku may be enormous, especially for long-
term economic impact, and thus may justify the additional
burden borne by Tohoku’s individual biobank contributors.
On the other hand, given the lack of primary focus,
the project’s response to the immediate health-related
needs and priorities of Tohoku’s most disadvantaged and
thus vulnerable population, the disaster survivors, may
never suffice (Table 2) [4,20,46]. Due to the project’s
lengthy duration, the burden on individuals stemming
from the collection and use of biodata is likely to be
considerably higher than for shorter term projects.
Moreover, as with nearly all types of biobank research,
those who benefit first and foremost – in terms of health
and economic considerations – will be our society as
a whole, while direct benefits to individual project
participants may be scarce. Such potential mismatch
between burden-bearers and research beneficiaries maythus provide good reason to regard the project as ethically
unjustified.
That is, the basic conflict here is between attending to
the immediate health care needs and concerns of disaster
survivors, versus the need for long term economic and
health care recovery in the disaster-stricken area and
Japan as a whole. While recognizing the potentially posi-
tive, long term impact of economic development in the
stricken area via investment in research infrastructure, it
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areas have not recovered and many local clinics remain
out of service. Thus, many survivors still have very limited
access to medical resources. It is reported for instance that
older people who have lost their families have become
socially as well as medically isolated, and are therefore
suffering unduly from declining health [12,47,48].
Thus, what is most needed is immediate disaster ser-
vices, along with achievable concrete plans for securing
access to sufficient health care and medical resources
[4,49], rather than a thin, speculative promise of future
health benefits [22]. Similarly, the immediate priority is
rapid recovery for health care in the stricken regions,
rather than the eventual improvement of Tohoku’s whole
healthcare system.
Of course, one should acknowledge that the ToMMo-
BbP has already begun supplying quake-struck areas with
a few researcher-physician fellows on one-year rotations.
There, they will provide medical guidance and collateral
preventive heal care services. This will contribute to the
health care recovery to some extent. Also, new masters
and doctoral courses for nurses and other medical
personnel will play a role in attracting young people to
Tohoku.
Yet, disaster survivors need considerably more immedi-
ate help. Additional hundreds of battle-ready medical staff,
more real physicians rather than researcher-physicians,
more access to medical facilities and resources, and more
specific treatment, rather than preventive medicine or
health research [46,49-51]. Yet, the disaster survivors
were never allowed to voice their feelings and opinions in
determining the project’s grand design. Instead, university
researchers determined the scope and framework of the
project in its entirety before announcing it to a commu-
nity still reeling from the loss and confusion caused by
the disaster. As such, what the project has done and
seeks to do seems clearly insufficient. Thus, it seems
necessary to try to bridge the gap between the survivors’
health needs, project expectations, and the ToMMo’s
ability to meet those more pressing needs [52]. Otherwise,
the responsiveness and reasonable access concerns will
remain unresolved. Only when more immediate needs are
met will it be appropriate to consider a research project
that may provide additional benefit to the stricken areas in
terms of long-range infrastructure and development.
Ethical analysis II: potential “benefits” and duress
Recently, as an ancillary benefit to contributors, several
biobanks have begun to provide individual contributors
with their research results – not only baseline healthcare
data (e.g. blood pressure; urinary sodium) but also
clinically-assessed genetic data [53,54]. Some biobanks
have also promised to provide individuals with special-
ist referrals whenever significant medical conditions areencountered. Indeed, in addition to health-checkups, the
ToMMo-BbP has actually promised to provide individual
research results, along with specialist referrals for those
with clinically significant medical conditions. The ToMMo
even states that, through this project, they will watch with
caring eyes the long-term health of disaster survivors
[55,56]. Since direct benefits to project enrollees are other-
wise scarce, offering such services seems wise, not only for
ToMMo researchers seeking more contributors, but also
desirable and workable as a strong incentive for potential
contributors [57,58].
On the other hand, such promised ‘benefits’ will also
strengthen the therapeutic misconception, or what Clayton
and Ross term the “diagnostic misconception” [59]. More-
over, the promise of individual genetic results as a potential
benefit disregards further consequences, such as that
disclosing individual genetic data may elicit additional
“anxiety and the burdens of follow-up [60].” And, in such
damaged, limited healthcare environs disaster survivors
need immediate access to healthcare. Thus, they may tend
to view any healthcare as better than none. So, it becomes
questionable whether those with an impulse to decline feel
they can really afford to reject project participation. They
may also feel obligated or be unduly pressured by the
surrounding community, especially when overall benefits
to the community require strong, individual, project par-
ticipation. Certainly, such vulnerability by itself may not
constitute unjust exploitation [25]. However, the potential
remains for “imposing an unfair share of the burden of
research participation” on a distressed population [61].
Also, given the level of shock, numbness and despair,
due to their devastation, it is possible that such subjects
“may be exploited without feeling particularly exploited,
or without believing they are being exploited [62].”
To ameliorate such concerns the ToMMo prepared
two distinct consent forms, one for health-checkups, the
other for biobanking research. However, as administered
by researchers intent on gathering such data, it remains
dubious that such forms alone can function to avoid
“participation under duress”. Rather, an alternative protocol
that completely separates recruitment staff from biobanking
researchers or health service providers should be consid-
ered, following due consideration and proactive consult-
ation with potential subjects and other relevant parties.
Current project status and further considerations
Despite many remaining ethical issues concerning its
design, the recruitment phase of the ToMMo-BbP began
on May 20, 2013. As of September 2013, more than 10,000
participants have been recruited with a consent rate of over
60% [63,64]. Because it is regarded partly as a social venue
or infrastructure for post-disaster restoration and recon-
struction, our society must engage in the national debate
about ToMMo-BbP. We need to reexamine our priorities
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storing the livelihoods of suffering survivors, and decide in
what way the project can truly contribute to this purpose.
Although the project was launched with little consider-
ation for or consultation with disaster survivors, project
researchers are now working via trial and error to estab-
lish the right path. They have created a public relations
section within the organization to promote communi-
cation with local communities [65]. Recently, they have
also begun to invite external research ethicists (including
the authors) for frank and open dialogue regarding the
project’s ethical issues [66]. Such efforts are appreciated,
and one may expect, through sincere discussion and dia-
logue with survivors about the project’s remaining prob-
lems and its desired future, that the project will improve
ethically and fulfill more of the real, immediate needs of
the disaster survivors and their stricken communities.
Finally, this case analysis may facilitate further discourse
regarding the responsiveness and reasonable availability
requirements, originally developed for clinical trials in
developing nations, via lengthy discussions within the
international ethics research community. First, it shows
clearly that these requirements can raise major research
issues, not just in developing nations but also in the
aftermath of natural disasters occurring in developed
nations [62]. Second, it demonstrates practical and polit-
ical difficulties in applying the requirements as applied to
biobanking research, since such requirements were devel-
oped primarily within the context of clinical trials. Finally,
this case also raises the question of whether knowledge
acquired by research on the chronically disadvantaged
can apply to the temporarily disadvantaged, i.e., disaster
survivors whose prior life circumstances may be restored
within a reasonably foreseeable future. This final point
has not been well-studied, and thus needs careful, future
analysis.
Summary
Immediately after the Great East Japan Earthquake in
2011, the government initiated a large-scale biobanking
project through Tohoku University to service the disaster-
stricken areas. This project began without consulting the
disaster survivors themselves. The goals were to both
boost post-disaster recovery and to promote nation-wide
medical innovation. Advisory committees were formed
to examine the ELSI of the project at both government
and university levels. However, our ethical analysis of
this project demonstrates that it still has many unresolved
ethical problems in its design and its implementation of
the just distribution of benefits. It may also unduly burden
and/or potentially exploit a vulnerable population in
crisis. Although the government and university researchers
emphasize the project’s anticipated role in societal recovery
within the quake-damaged regions and its potential benefitfor individual participants, it is highly questionable whether
such decades-long biobanking research, with only a distant
promise of speculative future social benefits, can be justi-
fied in lieu of a more timely response to the immediate
health needs and priorities of the disaster survivors. It is
also questionable whether duress concerns can be elimi-
nated during the recruitment process conducted in the
midst of such a crisis. Therefore, before the project pro-
ceeds further, we recommend that the ToMMo-BbP and
our society as a whole open a national discussion regarding
the project ethics, and that we reexamine what can and
should be our immediate response and first priorities in
support of the disaster survivors’ immediate needs.
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